2.5K Views
•
09:40 min
•
August 2nd, 2024
DOI :
August 2nd, 2024
•0:00
Introduction
0:51
Analyzing the Expression of TMOD3 in Normal Ovarian Tissues and Ovarian Cancer
2:23
Assessing the Effect of TMOD3 on Overall Survival and Progression‐Free Survival (PFS) in Ovarian Cancer Patients
4:15
TMOD3 Expression Analysis in Platinum‐Based Chemotherapy Resistant and Sensitive Patients and mRNA‐miRNA Analysis
6:56
Checking the Distribution of TMOD3 in Immune Cells and TMOD3 Coexpression Networks in Ovarian Cancer
İlgili Videolar
8.7K Views
9.5K Views
8.8K Views
8.5K Views
8.7K Views
5.7K Views
6.6K Views
2.7K Views
4.7K Views
3.1K Views
JoVE Hakkında
Telif Hakkı © 2020 MyJove Corporation. Tüm hakları saklıdır